S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

KAPA Kairos Pharma Ltd

2.10

1.13 (116.49%)

14 Jan 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Kairos Pharma (AMEX:KAPA)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Kairos Pharma Charts.

Kairos Pharma (AMEX:KAPA)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Kairos Pharma Charts.

Kairos Pharma Ltd News

Kairos Pharma to Present at the Lytham Partners Investor Healthcare Summit
Wednesday 8 January 2025 (7 days ago) • Business Wire

Form 8-K - Current report
Saturday 14 December 2024 (1 month ago) • Edgar (US Regulatory)

Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial
Wednesday 4 December 2024 (1 month ago) • Business Wire

Form 8-K - Current report
Wednesday 20 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 11 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 5 October 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 28 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 28 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 25 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 25 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 18 September 2024 (4 months ago) • Edgar (US Regulatory)

More Kairos Pharma Ltd News Articles

Verizon Communications

Australian SE All Ordina...

Newcrest Mining

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions